Exelixis : EXEL

All Exelixis Articles

61 Articles

Jon C. Ogg | Jan 31, 2014 at 8:55 AM EST

Russell 2000 Rebalance May Bring Huge Buying in Key Stocks

The Quantitative Strategies team at Jefferies closely monitors the index changes. 24/7 Wall St. screened the Jefferies list of stocks…

Jon C. Ogg | Jan 10, 2014 at 9:05 AM EST

Scorching Hot Biotech Tape: Small-Cap and Mid-Cap Stocks on Fire

Piper Jaffray analyst have a list of top biotech stock picks that could bring big gains for investors. The look…

Jon C. Ogg | Jul 12, 2013 at 8:15 AM EDT

Cowen’s Eight Biotech Stocks to Buy That Could Beat Earnings: Alexion, Ariad and More

ThinkstockBiotechnology stocks have had an extremely solid first half of the year. The analysts at Cowen Group point out that…

Jon C. Ogg | May 18, 2012 at 7:47 AM EDT

An Early Look at 2012 ASCO Biotech Cancer Stocks (DNDN, LLY, AMGN, ARIA, ARQL, ARRY, AVEO, BVTI, ABPI, BMY, CLDX, CYTR, CYCC, GALE, EXEL, GNBT, GHDX, IMGN, MYGN, NKTR, NLNK, ONXX, OPTR, PCYC, SGEN, SNSS, SNTA)

We are now just about two weeks away from the king of biotech and pharma events in cancer treatments. The 2012…

Jon C. Ogg | May 10, 2012 at 12:02 PM EDT

Taking An Early Look at 2012 ASCO Biotech/Cancer Stocks (DNDN, LLY, ARIA, ARRY, BVTI, ABPI, CLDX, CYTR, GALE, EXEL, GNBT, GHDX, IMGN, NKTR, NLNK, PCYC, SGEN)

It is now getting close to the middle of May, and that means one thing for biotech investors. The king…

Jon C. Ogg | Jan 31, 2012 at 8:27 AM EST

Top Analyst Upgrades & Downgrades (AMGN, AON, EQT, EXEL, IPI, ERIC, MDVN, NKE, NIHD, NYX, POT, RAX, RRC, SYMC, TSLA, UA, UNH)

Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street brokerage and research firms…

Jon C. Ogg | Nov 1, 2011 at 4:08 PM EDT

24/7 Wall St. Closing Bell (F, GM, NBG, ALU, YHOO, PFE, HD, ADM, BBX, EXEL)

The markets are beyond jittery. From a massively overbought market discounting a recession entirely back to a market dominated by the…

Douglas A. McIntyre | Apr 12, 2011 at 8:45 AM EDT

Top Active Trader Alert Stocks (AIB, ARMH, EXEL, EXTR, LVLT)

Active traders and day traders have many stocks to choose from this Tuesday morning. We are tracking news and moves…

Douglas A. McIntyre | Nov 18, 2010 at 8:51 AM EST

Top Active Trader Alert Stocks (DRYS, EXEL, HUM, LTXC)

Active traders and day traders have many stocks to choose from this Thursday morning. We are tracking news and moves…

Jon C. Ogg | May 12, 2010 at 4:33 PM EDT

BioHealth Business Daily (AEZS, ACHN, EXEL, MNTA, NBIX, OXGN, PGNX, SQNM, SCLN, VVUS, VICL)

There were many stocks in Biotech and BioHealth with plus-signs after their share prices today. The BioHealth Business Daily is…

Douglas A. McIntyre | Jul 29, 2009 at 9:09 AM EDT

Top Day Trader Alerts (ELRN, EXEL, LIFE, THQI, KG, BPSG, WCG, VPHM)

The following are some of the top stocks to watch for active trading today based on pre-market and after-hours volume…

Douglas A. McIntyre | May 27, 2009 at 1:34 PM EDT

Full 2009 ASCO Cancer & Oncology Primer (ABII, AEZS, ALTH, AMGN, APPA, ARQL, BMY, CLDX, CELG, CTIC, CGRB, LLY, EXEL, GHDX, GSK, IMGN, MEDX, MDVN, MITI, OGXI, OSIP, PPHM, PFE, ROSG, SNTA, TRBN, ZIOP, ZGEN)

We have compiled an updated lengthy 2009 American Society of Clinical Oncology, or ASCO, document showing many company cancer data…

Douglas A. McIntyre | May 14, 2009 at 4:56 PM EDT

Previewing 2009 ASCO Abstracts (ABII, ALTH, ARQL, CLDX, CTIC, CGRB, LLY, EXEL, GHDX, GSK, IMGN, MEDX, MDVN, OGXI, OSIP, PPHM, PFE, SNTA, ZIOP)

We are just about to get the first round of abstracts from companies presenting data at this year’s American Society…

Douglas A. McIntyre | Oct 29, 2008 at 7:08 AM EDT

Top Analyst Upgrades & Downgrades (CEG, DENN, ODSY, ARO, D, EXEL, JNJ, VOCS, ZGEN)

These are some of the other non-tech analyst upgrades and downgrades from Wall Street firms this Wednesday morning: Constellation Energy…

Douglas A. McIntyre | Mar 10, 2008 at 2:25 PM EDT

Biotech Monday (CRIS, CGRB, EXEL, MNKD, PDLI, SQNM, TCM)

Curis Inc. (NASDAQ: CRIS) shares down 18% after development partner Wyeth terminated their contract that focused on cancer treatment developments.…

1 2 3 4 5

Exelixis : EXEL

All Exelixis Articles

Russell 2000 Rebalance May Bring Huge Buying in Key Stocks

Scorching Hot Biotech Tape: Small-Cap and Mid-Cap Stocks on Fire

Cowen’s Eight Biotech Stocks to Buy That Could Beat Earnings: Alexion, Ariad and More

An Early Look at 2012 ASCO Biotech Cancer Stocks (DNDN, LLY, AMGN, ARIA, ARQL, ARRY, AVEO, BVTI, ABPI, BMY, CLDX, CYTR, CYCC, GALE, EXEL, GNBT, GHDX, IMGN, MYGN, NKTR, NLNK, ONXX, OPTR, PCYC, SGEN, SNSS, SNTA)

Taking An Early Look at 2012 ASCO Biotech/Cancer Stocks (DNDN, LLY, ARIA, ARRY, BVTI, ABPI, CLDX, CYTR, GALE, EXEL, GNBT, GHDX, IMGN, NKTR, NLNK, PCYC, SGEN)

Top Analyst Upgrades & Downgrades (AMGN, AON, EQT, EXEL, IPI, ERIC, MDVN, NKE, NIHD, NYX, POT, RAX, RRC, SYMC, TSLA, UA, UNH)

24/7 Wall St. Closing Bell (F, GM, NBG, ALU, YHOO, PFE, HD, ADM, BBX, EXEL)

Top Active Trader Alert Stocks (AIB, ARMH, EXEL, EXTR, LVLT)

Top Active Trader Alert Stocks (DRYS, EXEL, HUM, LTXC)

BioHealth Business Daily (AEZS, ACHN, EXEL, MNTA, NBIX, OXGN, PGNX, SQNM, SCLN, VVUS, VICL)

Top Day Trader Alerts (ELRN, EXEL, LIFE, THQI, KG, BPSG, WCG, VPHM)

Full 2009 ASCO Cancer & Oncology Primer (ABII, AEZS, ALTH, AMGN, APPA, ARQL, BMY, CLDX, CELG, CTIC, CGRB, LLY, EXEL, GHDX, GSK, IMGN, MEDX, MDVN, MITI, OGXI, OSIP, PPHM, PFE, ROSG, SNTA, TRBN, ZIOP, ZGEN)

Previewing 2009 ASCO Abstracts (ABII, ALTH, ARQL, CLDX, CTIC, CGRB, LLY, EXEL, GHDX, GSK, IMGN, MEDX, MDVN, OGXI, OSIP, PPHM, PFE, SNTA, ZIOP)

Top Analyst Upgrades & Downgrades (CEG, DENN, ODSY, ARO, D, EXEL, JNJ, VOCS, ZGEN)

Biotech Monday (CRIS, CGRB, EXEL, MNKD, PDLI, SQNM, TCM)

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Warren Buffett’s Parting Gift to Investors Is Crushing the Market 6 Months Later

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s

College-Educated Families Earned $242,200 While Others Made $42,200, Here's Why the Gap Widened

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Exelixis : EXEL

All Exelixis Articles

Russell 2000 Rebalance May Bring Huge Buying in Key Stocks

Scorching Hot Biotech Tape: Small-Cap and Mid-Cap Stocks on Fire

Cowen’s Eight Biotech Stocks to Buy That Could Beat Earnings: Alexion, Ariad and More

An Early Look at 2012 ASCO Biotech Cancer Stocks (DNDN, LLY, AMGN, ARIA, ARQL, ARRY, AVEO, BVTI, ABPI, BMY, CLDX, CYTR, CYCC, GALE, EXEL, GNBT, GHDX, IMGN, MYGN, NKTR, NLNK, ONXX, OPTR, PCYC, SGEN, SNSS, SNTA)

Taking An Early Look at 2012 ASCO Biotech/Cancer Stocks (DNDN, LLY, ARIA, ARRY, BVTI, ABPI, CLDX, CYTR, GALE, EXEL, GNBT, GHDX, IMGN, NKTR, NLNK, PCYC, SGEN)

Top Analyst Upgrades & Downgrades (AMGN, AON, EQT, EXEL, IPI, ERIC, MDVN, NKE, NIHD, NYX, POT, RAX, RRC, SYMC, TSLA, UA, UNH)

24/7 Wall St. Closing Bell (F, GM, NBG, ALU, YHOO, PFE, HD, ADM, BBX, EXEL)

Top Active Trader Alert Stocks (AIB, ARMH, EXEL, EXTR, LVLT)

Top Active Trader Alert Stocks (DRYS, EXEL, HUM, LTXC)

BioHealth Business Daily (AEZS, ACHN, EXEL, MNTA, NBIX, OXGN, PGNX, SQNM, SCLN, VVUS, VICL)

Top Day Trader Alerts (ELRN, EXEL, LIFE, THQI, KG, BPSG, WCG, VPHM)

Full 2009 ASCO Cancer & Oncology Primer (ABII, AEZS, ALTH, AMGN, APPA, ARQL, BMY, CLDX, CELG, CTIC, CGRB, LLY, EXEL, GHDX, GSK, IMGN, MEDX, MDVN, MITI, OGXI, OSIP, PPHM, PFE, ROSG, SNTA, TRBN, ZIOP, ZGEN)

Previewing 2009 ASCO Abstracts (ABII, ALTH, ARQL, CLDX, CTIC, CGRB, LLY, EXEL, GHDX, GSK, IMGN, MEDX, MDVN, OGXI, OSIP, PPHM, PFE, SNTA, ZIOP)

Top Analyst Upgrades & Downgrades (CEG, DENN, ODSY, ARO, D, EXEL, JNJ, VOCS, ZGEN)

Biotech Monday (CRIS, CGRB, EXEL, MNKD, PDLI, SQNM, TCM)

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Warren Buffett’s Parting Gift to Investors Is Crushing the Market 6 Months Later

Featured Reads

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s

College-Educated Families Earned $242,200 While Others Made $42,200, Here's Why the Gap Widened